Veterinary Regenerative Medicine Market - By Product Type: Stem Cell Therapy, Platelet-Rich Plasma, Exosome Therapy; By Application: Orthopedics; Dermatology, Organ Repair, By Animal Type: Companion Animals, Equine, Livestock; By Region: North America, Europe, Asia-Pacific Latin America and Middle East and Africa.
The global veterinary regenerative medicine market is projected to grow from USD 1.2 billion in 2025 to USD 3.8 billion by 2031, at a 21.4% CAGR, driven by advanced stem cell therapies and exosome technologies.
Market Segmentation
By Product Type
By Application
By Animal Type
2. Key Growth Drivers
1. Clinical Efficacy Breakthroughs
2. Manufacturing Innovations
3. Regulatory Advancements
3. Competitive Landscape
|
Company |
Breakthrough |
Market Impact |
|
VetStem |
Equine tendon MSC therapy |
60% US market share |
|
Gallant |
Canine exosome platform |
$85M Series C funding |
|
Ardent Cell |
Off-the-shelf CaniCell® |
500+ clinic network |
4. Future Outlook (2026-2031)
Need help?
Chat with our team in a minute.